Cibele Rocha-Resende
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Cibele Rocha-Resende has a total of 178 co-authors. Here are the top co-authors by number of shared publications:
- Silvia Guatimosim
Universidade Federal de Minas Gerais
19 shared publications - Douglas L. Mann
Center for Cardiovascular Research, Cardiovascular Division Washington University School of Medicine St. Louis Missouri USA
9 shared publications - Luigi Adamo
Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
6 shared publications - Robson Augusto Souza Santos
Federal University of Minas Gerais
6 shared publications - Marco Antonio Maximo Prado
Robarts Research Institute, The University of Western Ontario, London, Canada
4 shared publications - Rodrigo Ribeiro Resende
Departamento de Bioquímica e Imunologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil
4 shared publications
Latest Publications
- Open Access
- 1 August 2026
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
Enhanced monocyte influx to the injured heart at dark phase exacerbates cardiac hypertrophy in a mouse model of Takotsubo cardiomyopathy
While circadian rhythms are critical regulators of cardiovascular physiopathology, their role in Takotsubo Syndrome (TTS) remains poorly understood. This study aimed to investigate the influence of time-of-day on cardiac hypertrophy and inflammation in a mouse model of TTS induced by isoproterenol (ISO) administration. Female mice were injected with saline (Sal) or ISO at the beginning of the light (ZT0) or dark phase (ZT12). Our data show that mice treated with ISO at ZT12 developed more prominent cardiac hypertrophy and exhibited worse cardiomyocyte calcium handling. This was accompanied by an enhanced accumulation of leukocytes in the hearts of ISO/ZT12 compared with ISO/ZT0 mice. Flow cytometry analysis revealed an exacerbation in the number CD64 hi/int Ly6C hi/lo CCR2 + monocytes/macrophages at ZT12 indicating a time-of-day influence on the inflammatory response following ISO administration. Of note, these differences were not secondary to differences in initial tissue injury as assessed by Evans Blue uptake by necrotic cells. However, cardiac expression of Ccl2/7 was significantly higher in the hearts of ISO/ZT12 in comparison to ISO/ZT0, suggesting the involvement of the CCL2/CCR2 signaling axis in the enhanced recruitment of monocytes. Finally, pharmacological and genetic strategies used to prevent CCR2-dependent recruitment of monocytes ameliorated the cardiac hypertrophy induced by ISO at ZT12, indicating that the CCL2/CCR2 signaling axis is crucial to the temporal dependent effects of ISO. Taken together, our data show a previously unrecognized role of the time-of-day on cardiac inflammation following adrenergic overload.
- 1 August 2026
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
Open AccessEnhanced monocyte influx to the injured heart at dark phase exacerbates cardiac hypertrophy in a mouse model of Takotsubo cardiomyopathy
While circadian rhythms are critical regulators of cardiovascular physiopathology, their role in Takotsubo Syndrome (TTS) remains poorly understood. This study aimed to investigate the influence of time-of-day on cardiac hypertrophy and inflammation in a mouse model of TTS induced by isoproterenol (ISO) administration. Female mice were injected with saline (Sal) or ISO at the beginning of the light (ZT0) or dark phase (ZT12). Our data show that mice treated with ISO at ZT12 developed more prominent cardiac hypertrophy and exhibited worse cardiomyocyte calcium handling. This was accompanied by an enhanced accumulation of leukocytes in the hearts of ISO/ZT12 compared with ISO/ZT0 mice. Flow cytometry analysis revealed an exacerbation in the number CD64 hi/int Ly6C hi/lo CCR2 + monocytes/macrophages at ZT12 indicating a time-of-day influence on the inflammatory response following ISO administration. Of note, these differences were not secondary to differences in initial tissue injury as assessed by Evans Blue uptake by necrotic cells. However, cardiac expression of Ccl2/7 was significantly higher in the hearts of ISO/ZT12 in comparison to ISO/ZT0, suggesting the involvement of the CCL2/CCR2 signaling axis in the enhanced recruitment of monocytes. Finally, pharmacological and genetic strategies used to prevent CCR2-dependent recruitment of monocytes ameliorated the cardiac hypertrophy induced by ISO at ZT12, indicating that the CCL2/CCR2 signaling axis is crucial to the temporal dependent effects of ISO. Taken together, our data show a previously unrecognized role of the time-of-day on cardiac inflammation following adrenergic overload.
- 1 March 2026
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 330 (3) , C706-C714
Loss of α7 nicotinic acetylcholine receptor exacerbates adrenergic-induced cardiac damage
Although α7nAChR has been implicated in cardioprotection through its anti-inflammatory properties, the mechanisms underlying these effects remain elusive. We demonstrate that α7nAChR deficiency heightens susceptibility to adrenergic-induced injury, characterized by enhanced cardiomyocyte death and monocyte infiltration. Our findings confirm the anti-inflammatory role of α7nAChR and reveal its cell-autonomous prosurvival effects on cardiomyocytes, broadening our understanding of mechanisms driving cholinergic cardioprotection. This work positions α7nAChR as a regulator of myocardial resilience and highlights its therapeutic potential.
- 1 March 2026
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 330 (3) , C706-C714
Loss of α7 nicotinic acetylcholine receptor exacerbates adrenergic-induced cardiac damage
Although α7nAChR has been implicated in cardioprotection through its anti-inflammatory properties, the mechanisms underlying these effects remain elusive. We demonstrate that α7nAChR deficiency heightens susceptibility to adrenergic-induced injury, characterized by enhanced cardiomyocyte death and monocyte infiltration. Our findings confirm the anti-inflammatory role of α7nAChR and reveal its cell-autonomous prosurvival effects on cardiomyocytes, broadening our understanding of mechanisms driving cholinergic cardioprotection. This work positions α7nAChR as a regulator of myocardial resilience and highlights its therapeutic potential.
- 1 May 2024
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 326 (5) , C1334-C1344
β-Adrenergic signaling drives structural and functional maturation of mouse cardiomyocytes
Maturation involves a series of morphofunctional alterations vital to heart development. Its regulatory mechanisms are only now being unveiled. Evidence implies that adrenergic signaling regulates cardiac maturation, but the mechanisms are poorly understood. To address this point, we blocked β-ARs or performed sympathectomy followed by rescue experiments with isoproterenol in neonatal mice. Our study identifies the β-AR stimuli as a maturation signal for cardiomyocytes and highlights the importance of this pathway in cardiac regeneration therapies.
- 1 May 2024
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 326 (5) , C1334-C1344
β-Adrenergic signaling drives structural and functional maturation of mouse cardiomyocytes
Maturation involves a series of morphofunctional alterations vital to heart development. Its regulatory mechanisms are only now being unveiled. Evidence implies that adrenergic signaling regulates cardiac maturation, but the mechanisms are poorly understood. To address this point, we blocked β-ARs or performed sympathectomy followed by rescue experiments with isoproterenol in neonatal mice. Our study identifies the β-AR stimuli as a maturation signal for cardiomyocytes and highlights the importance of this pathway in cardiac regeneration therapies.
- 1 May 2023
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 324 (5) , H655-H656
Reply to Madias
- 1 May 2023
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 324 (5) , H655-H656
Reply to Madias
- Open Access
- 30 March 2023
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (3) , e0282921
Necrotic cardiac myocytes skew macrophage polarization towards a classically activated phenotype
Necrotic and dying cells release damage-associated molecular patterns (DAMPs) that can initiate sterile inflammatory responses in the heart. Although macrophages are essential for myocardial repair and regeneration, the effect of DAMPs on macrophage activation remains unclear. To address this gap in knowledge we studied the effect of necrotic cardiac myocyte extracts on primary peritoneal macrophage (PPM) cultures in vitro. We first performed unbiased transcriptomic profiling with RNA-sequencing of PPMs cultured for up to 72 hours in the presence and absence of: 1) necrotic cell extracts (NCEs) from necrotic cardiac myocytes in order to mimic the release of DAMPs; 2) lipopolysaccharide (LPS), which is known to polarize macrophages towards a classically activated phenotype and 3) Interleukin-4 (IL-4), which is known to promote polarization of macrophages towards an alternatively activated phenotype. NCEs provoke changes in differential gene expression (DEGs) that had considerable overlap with LPS-induced changes, suggesting that NCEs promote macrophage polarization towards a classically activated phenotype. Treating NCEs with proteinase-K abolished the effects of NCEs on macrophage activation, whereas NCE treatment with DNase and RNase did not affect macrophage activation. Stimulation of macrophage cultures with NCEs and LPS resulted in a significant increase in macrophage phagocytosis and interleukin-1β secretion, whereas treatment with IL-4 had no significant effect on phagocytosis and interleukin-1β. Taken together, our findings suggest that proteins released from necrotic cardiac myocytes are sufficient to skew the polarization of macrophages towards a classically activated phenotype.
- 30 March 2023
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (3) , e0282921
Open AccessNecrotic cardiac myocytes skew macrophage polarization towards a classically activated phenotype
Necrotic and dying cells release damage-associated molecular patterns (DAMPs) that can initiate sterile inflammatory responses in the heart. Although macrophages are essential for myocardial repair and regeneration, the effect of DAMPs on macrophage activation remains unclear. To address this gap in knowledge we studied the effect of necrotic cardiac myocyte extracts on primary peritoneal macrophage (PPM) cultures in vitro. We first performed unbiased transcriptomic profiling with RNA-sequencing of PPMs cultured for up to 72 hours in the presence and absence of: 1) necrotic cell extracts (NCEs) from necrotic cardiac myocytes in order to mimic the release of DAMPs; 2) lipopolysaccharide (LPS), which is known to polarize macrophages towards a classically activated phenotype and 3) Interleukin-4 (IL-4), which is known to promote polarization of macrophages towards an alternatively activated phenotype. NCEs provoke changes in differential gene expression (DEGs) that had considerable overlap with LPS-induced changes, suggesting that NCEs promote macrophage polarization towards a classically activated phenotype. Treating NCEs with proteinase-K abolished the effects of NCEs on macrophage activation, whereas NCE treatment with DNase and RNase did not affect macrophage activation. Stimulation of macrophage cultures with NCEs and LPS resulted in a significant increase in macrophage phagocytosis and interleukin-1β secretion, whereas treatment with IL-4 had no significant effect on phagocytosis and interleukin-1β. Taken together, our findings suggest that proteins released from necrotic cardiac myocytes are sufficient to skew the polarization of macrophages towards a classically activated phenotype.
- 1 February 2023
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 324 (2) , H229-H240
Refining the reproducibility of a murine model of stress-induced reversible cardiomyopathy
The present study highlights the importance of sexual dimorphism with respect to isoproterenol injury, as well as the importance of animal handling and welfare to obtain reproducible results from investigator to investigator. Based on serial observations of animal recovery (locomotor activity and grooming behavior), troponin I release, and inflammation, we identified that the method used to restrain the mice for the intraperitoneal injection was the single greatest source of variability in this model.
- 1 February 2023
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 324 (2) , H229-H240
Refining the reproducibility of a murine model of stress-induced reversible cardiomyopathy
The present study highlights the importance of sexual dimorphism with respect to isoproterenol injury, as well as the importance of animal handling and welfare to obtain reproducible results from investigator to investigator. Based on serial observations of animal recovery (locomotor activity and grooming behavior), troponin I release, and inflammation, we identified that the method used to restrain the mice for the intraperitoneal injection was the single greatest source of variability in this model.
- 1 April 2022
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 322 (4) , C794-C801
Neuronal cholinergic signaling constrains norepinephrine activity in the heart
It is well known that cholinergic hypofunction contributes to cardiac pathology, yet, the mechanisms involved remain unclear. Our previous study has shown that genetically engineered model of cholinergic deficit, the vesicular acetylcholine transporter knockdown homozygous (VAChT KDHOM) mice, exhibit pathological cardiac remodeling and a gradual increase in cardiac mass with aging. Given that an increase in cardiac mass is often caused by adrenergic hyperactivity, we hypothesized that VAChT KDHOM mice might have an increase in cardiac norepinephrine (NE) levels. We thus investigated the temporal changes in NE content in the heart from 3-, 6-, and 12-mo-old VAChT mutants. Interestingly, mice with cholinergic hypofunction showed a gradual elevation in cardiac NE content, which was already increased at 6 mo of age. Consistent with this finding, 6-mo-old VAChT KDHOM mice showed enhanced sympathetic activity and a greater abundance of tyrosine hydroxylase positive sympathetic nerves in the heart. VAChT mutants exhibited an increase in peak calcium transient, and mitochondrial oxidative stress in cardiomyocytes along with enhanced G protein-coupled receptor kinase 5 (GRK5) and nuclear factor of activated T-cells (NFAT) staining in the heart. These are known targets of adrenergic signaling in the cell. Moreover, vagotomized-mice displayed an increase in cardiac NE content confirming the data obtained in VAChT KDHOM mice. Establishing a causal relationship between acetylcholine and NE, VAChT KDHOM mice treated with pyridostigmine, a cholinesterase inhibitor, showed reduced cardiac NE content, rescuing the phenotype. Our findings unveil a yet unrecognized role of cholinergic signaling as a modulator of cardiac NE, providing novel insights into the mechanisms that drive autonomic imbalance.
- 1 April 2022
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 322 (4) , C794-C801
Neuronal cholinergic signaling constrains norepinephrine activity in the heart
It is well known that cholinergic hypofunction contributes to cardiac pathology, yet, the mechanisms involved remain unclear. Our previous study has shown that genetically engineered model of cholinergic deficit, the vesicular acetylcholine transporter knockdown homozygous (VAChT KDHOM) mice, exhibit pathological cardiac remodeling and a gradual increase in cardiac mass with aging. Given that an increase in cardiac mass is often caused by adrenergic hyperactivity, we hypothesized that VAChT KDHOM mice might have an increase in cardiac norepinephrine (NE) levels. We thus investigated the temporal changes in NE content in the heart from 3-, 6-, and 12-mo-old VAChT mutants. Interestingly, mice with cholinergic hypofunction showed a gradual elevation in cardiac NE content, which was already increased at 6 mo of age. Consistent with this finding, 6-mo-old VAChT KDHOM mice showed enhanced sympathetic activity and a greater abundance of tyrosine hydroxylase positive sympathetic nerves in the heart. VAChT mutants exhibited an increase in peak calcium transient, and mitochondrial oxidative stress in cardiomyocytes along with enhanced G protein-coupled receptor kinase 5 (GRK5) and nuclear factor of activated T-cells (NFAT) staining in the heart. These are known targets of adrenergic signaling in the cell. Moreover, vagotomized-mice displayed an increase in cardiac NE content confirming the data obtained in VAChT KDHOM mice. Establishing a causal relationship between acetylcholine and NE, VAChT KDHOM mice treated with pyridostigmine, a cholinesterase inhibitor, showed reduced cardiac NE content, rescuing the phenotype. Our findings unveil a yet unrecognized role of cholinergic signaling as a modulator of cardiac NE, providing novel insights into the mechanisms that drive autonomic imbalance.
- 1 August 2021
- Published by Elsevier in Journal of Molecular and Cellular Cardiology
- Vol. 157, 98-103
B cells modulate the expression of MHC-II on cardiac CCR2− macrophages
- 1 August 2021
- Published by Elsevier in Journal of Molecular and Cellular Cardiology
- Vol. 157, 98-103
B cells modulate the expression of MHC-II on cardiac CCR2− macrophages
- 1 April 2021
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 320 (4) , C602-C612
Increased cholinergic activity under conditions of low estrogen leads to adverse cardiac remodeling
Cholinesterase inhibitors are used in postmenopausal women for the treatment of neurodegenerative diseases. Despite their widespread use in the clinical practice, little is known about the impact of augmented cholinergic signaling on cardiac function under reduced estrogen conditions. To address this gap, we subjected a genetically engineered murine model of systemic vesicular acetylcholine transporter overexpression ( Chat-ChR2) to ovariectomy and evaluated cardiac parameters. Left-ventricular function was similar between Chat-ChR2 and wild-type (WT) mice. Following ovariectomy, WT mice showed signs of cardiac hypertrophy. Conversely, ovariectomized (OVX) Chat-ChR2 mice evolved to cardiac dilation and failure. Transcript levels for cardiac stress markers atrial natriuretic peptide (ANP) and B-type natriuretic peptide (BNP) were similarly upregulated in WT/OVX and Chat-ChR2/OVX mice. 17β-Estradiol (E2) treatment normalized cardiac parameters in Chat-ChR2/OVX to the Chat-ChR2/SHAM levels, providing a link between E2 status and the aggravated cardiac response in this model. To investigate the cellular basis underlying the cardiac alterations, ventricular myocytes were isolated and their cellular area and contractility were assessed. Myocytes from WT/OVX mice were wider than WT/SHAM, an indicative of concentric hypertrophy, but their fractional shortening was similar. Conversely, Chat-ChR2/OVX myocytes were elongated and presented contractile dysfunction. E2 treatment again prevented the structural and functional changes in Chat-ChR2/OVX myocytes. We conclude that hypercholinergic mice under reduced estrogen conditions do not develop concentric hypertrophy, a critical compensatory adaptation, evolving toward cardiac dilation and failure. This study emphasizes the importance of understanding the consequences of cholinesterase inhibition, used clinically to treat dementia, for cardiac function in postmenopausal women.
- 1 April 2021
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 320 (4) , C602-C612
Increased cholinergic activity under conditions of low estrogen leads to adverse cardiac remodeling
Cholinesterase inhibitors are used in postmenopausal women for the treatment of neurodegenerative diseases. Despite their widespread use in the clinical practice, little is known about the impact of augmented cholinergic signaling on cardiac function under reduced estrogen conditions. To address this gap, we subjected a genetically engineered murine model of systemic vesicular acetylcholine transporter overexpression ( Chat-ChR2) to ovariectomy and evaluated cardiac parameters. Left-ventricular function was similar between Chat-ChR2 and wild-type (WT) mice. Following ovariectomy, WT mice showed signs of cardiac hypertrophy. Conversely, ovariectomized (OVX) Chat-ChR2 mice evolved to cardiac dilation and failure. Transcript levels for cardiac stress markers atrial natriuretic peptide (ANP) and B-type natriuretic peptide (BNP) were similarly upregulated in WT/OVX and Chat-ChR2/OVX mice. 17β-Estradiol (E2) treatment normalized cardiac parameters in Chat-ChR2/OVX to the Chat-ChR2/SHAM levels, providing a link between E2 status and the aggravated cardiac response in this model. To investigate the cellular basis underlying the cardiac alterations, ventricular myocytes were isolated and their cellular area and contractility were assessed. Myocytes from WT/OVX mice were wider than WT/SHAM, an indicative of concentric hypertrophy, but their fractional shortening was similar. Conversely, Chat-ChR2/OVX myocytes were elongated and presented contractile dysfunction. E2 treatment again prevented the structural and functional changes in Chat-ChR2/OVX myocytes. We conclude that hypercholinergic mice under reduced estrogen conditions do not develop concentric hypertrophy, a critical compensatory adaptation, evolving toward cardiac dilation and failure. This study emphasizes the importance of understanding the consequences of cholinesterase inhibition, used clinically to treat dementia, for cardiac function in postmenopausal women.
- 12 March 2021
- Published by Springer Nature in Nature Reviews Cardiology
- Vol. 18 (10) , 735
Publisher Correction: Reappraising the role of inflammation in heart failure
- 12 March 2021
- Published by Springer Nature in Nature Reviews Cardiology
- Vol. 18 (10) , 735
Publisher Correction: Reappraising the role of inflammation in heart failure